Translational Development of a Zr-89-Labeled Inhibitor of Prostate-specific Membrane Antigen for PET Imaging in Prostate Cancer
Purpose: We present here a Zr-89-labeled inhibitor of prostate-specific membrane antigen (PSMA) as a complement to the already established F-18- or Ga-68-ligands. Procedures: The precursor PSMA-DFO (ABX) was used for Zr-89-labeling. This is not an antibody, but a peptide analogue of the precursor fo...
Main Authors: | Dietlein, F. (Author), Dietlein, M. (Author), Drzezga, A. (Author), Endepols, H. (Author), Fischer, T. (Author), Hohberg, M. (Author), Neumaier, B. (Author), Schomäcker, K. (Author), Tawadros, S.-G (Author), Vázquez, S.M (Author), Zimmermanns, B. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Science and Business Media Deutschland GmbH
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Production and Semi-Automated Processing of <sup>89</sup>Zr Using a Commercially Available TRASIS MiniAiO Module
by: Vijay Gaja, et al.
Published: (2020-06-01) -
A generic 89Zr labeling method to quantify the in vivo pharmacokinetics of liposomal nanoparticles with positron emission tomography
by: Li N, et al.
Published: (2017-04-01) -
Detection limit of 89Zr-labeled T cells for cellular tracking: an in vitro imaging approach using clinical PET/CT and PET/MRI
by: Laura M. Lechermann, et al.
Published: (2020-07-01) -
Bone marrow cell homing to sites of acute tibial fracture: 89Zr-oxine cell labeling with positron emission tomographic imaging in a mouse model
by: Kingsley O. Asiedu, et al.
Published: (2018-12-01) -
Recent Advances in Zirconium-89 Chelator Development
by: Nikunj B. Bhatt, et al.
Published: (2018-03-01)